Finance

Beta
Lists
FBLG:NASDAQ
Fibrobiologics Inc
$0.77
+2.61%
(+0.020) 1D
Jun 24, 1:39:55 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FBLG...
Open
$0.75
High
$0.78
Low
$0.75
Mkt. cap
4.01M
Avg. vol.
239.80K
Volume
129.35K
52-wk high
$15.15
52-wk low
$0.75
EPS
-$7.50
Shares outstanding
5.21M
No. of employees
15
Open
$0.75
High
$0.78
Low
$0.75
Mkt. cap
4.01M
Avg. vol.
239.80K
Volume
129.35K
52-wk high
$15.15
52-wk low
$0.75
EPS
-$7.50
Shares outstanding
5.21M
No. of employees
15
News stories
From sources across the web
About Fibrobiologics Inc
CEO-
Employees15
Founded2021
HeadquartersHouston, Texas, United States
SectorBiotechnology
Websitefibrobiologics.com
Analyst Ratings
Based on 3 analysts giving stock ratings to FBLG in the past 3 months
Buy
Buy
1
Hold
2
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for FBLG in the last 3 months.
Highest
Current $0.77
$8.00 (+939.10%)
Average
$8.00 (+939.10%)
Lowest
$8.00 (+939.10%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Michael Okunewitch
Maxim Group
Hold
Downgraded
-
-
05/04/2026
Matthew Caufield
H.C. Wainwright
Buy
Maintained
$8.00
+939.1%
04/16/2026
Jason Kolbert
D. Boral Capital
Hold
Downgraded
-
-
03/26/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.04M
2.79M
797.00K
2.95M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.45M
2.25M
1.79M
2.12M
Operating expense
4.49M
5.04M
2.59M
5.07M
Total operating expenses
4.49M
5.04M
2.59M
5.07M
Operating income
-4.49M
-5.04M
-2.59M
-5.07M
Other non operating income
-218.00K
-813.00K
-475.00K
54.00K
EBT including unusual items
-4.66M
-5.78M
-3.24M
-5.00M
EBT excluding unusual items
-4.66M
-5.78M
-3.24M
-5.00M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.66M
-5.78M
-3.24M
-5.00M
Net profit margin
-
-
-
-
Earnings per share
-2.40
-2.60
-0.60
-1.33
Interest and investment income
50.00K
73.00K
25.00K
20.00K
Interest expense
-
-
-204.00K
-4.00K
Net interest expenses
50.00K
73.00K
-179.00K
16.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.43M
-4.97M
-2.52M
-5.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer